The new regulations in the UK are so much better for small innovative companies. AI Gemini has jotted down point by point. If I count them, there probably more than 5 points. For example SI 87 itself introduced many improvements. So with FlaskWorks, you don't need another clinical trials if you can show equal results or better results. This SI 87 is huge, huge improvement. NWBO can tap community hospitals after this SI 87 is live. Previously, only Central location and that is Sawston. Why SI 87 is introduced folks? Because UK wanted to help patients so they can just go to hospitals nearby. Is SI 87 good for small cell therapy like NWBO? Yes of course absolutely. UK seems to know it. And there are other regulations such as aligned regulations between MHRA and NICE so the approvals come at the same time. Is that why we still wait for approval? Because we are waiting from NICE results of deliberations on March 3? Folks, don't think I know this. Nope I don't know all this. I juat asked AI and AI analyzed them for me.
Market Data 
Markets 
AI
